Remarkable activity of novel agents bortezomib and thalidomi…
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Article, Chapter
Full text availability for this item
Journal:
Blood
Opens in new Window
Coverage:
- 1946-01-01~present; volume:1~present;issue:1~present
Journal:
Blood
Opens in new Window
Coverage:
- 1946~12 months ago; volume:1~12 months ago;issue:1~12 months ago